Mereo Biopharma Group Stock One Year Return
| 0A9G Stock | 3.55 0.15 4.41% |
Mereo BioPharma Group fundamentals help investors to digest information that contributes to Mereo BioPharma's financial success or failures. It also enables traders to predict the movement of Mereo Stock. The fundamental analysis module provides a way to measure Mereo BioPharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mereo BioPharma stock.
Mereo | One Year Return |
Mereo BioPharma Group Company One Year Return Analysis
Mereo BioPharma's One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
More About One Year Return | All Equity Analysis
One Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
| Competition |
Based on the recorded statements, Mereo BioPharma Group has an One Year Return of 0.0%. This indicator is about the same for the Commercial Services & Supplies average (which is currently at 0.0) sector and about the same as Industrials (which currently averages 0.0) industry. This indicator is about the same for all United Kingdom stocks average (which is currently at 0.0).
Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Mereo Fundamentals
| Return On Equity | -0.74 | ||||
| Return On Asset | -0.31 | ||||
| Operating Margin | (38.07) % | ||||
| Current Valuation | 2.68 B | ||||
| Shares Owned By Insiders | 1.02 % | ||||
| Shares Owned By Institutions | 68.29 % | ||||
| Revenue | 1000 K | ||||
| Gross Profit | 936 K | ||||
| EBITDA | (37.48 M) | ||||
| Net Income | (34.2 M) | ||||
| Book Value Per Share | 0.47 X | ||||
| Cash Flow From Operations | (38.82 M) | ||||
| Earnings Per Share | (0.28) X | ||||
| Target Price | 4.38 | ||||
| Number Of Employees | 33 | ||||
| Beta | 0.97 | ||||
| Retained Earnings | (331.16 M) |
About Mereo BioPharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mereo BioPharma Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mereo BioPharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mereo BioPharma Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Mereo Stock Analysis
When running Mereo BioPharma's price analysis, check to measure Mereo BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo BioPharma is operating at the current time. Most of Mereo BioPharma's value examination focuses on studying past and present price action to predict the probability of Mereo BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mereo BioPharma's price. Additionally, you may evaluate how the addition of Mereo BioPharma to your portfolios can decrease your overall portfolio volatility.